David A. Spencer

David A. Spencer David A. Spencer is the Founder and Chief Executive Officer for Vestigo Aerospace, Inc. As an aerospace engineer, Spencer designs and operates planetary space science missions, and develops space technology. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'David A. Spencer', query time: 0.04s Refine Results
  1. 1
    LightSail 2 Solar Sail Control and Orbit Evolution

    LightSail 2 Solar Sail Control and Orbit Evolution by Justin R. Mansell, John M. Bellardo, Bruce Betts, Barbara Plante, David A. Spencer

    Published 2023-06-01
    Get full text
    Article
  2. 2
    Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic

    Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic by David A. Spencer, Mariya B. Shapiro, Nancy L. Haigwood, Nancy L. Haigwood, Ann J. Hessell

    Published 2021-05-01
    Get full text
    Article
  3. 3
    Persistence of HIV-1 Env-Specific Plasmablast Lineages in Plasma Cells after Vaccination in Humans

    Persistence of HIV-1 Env-Specific Plasmablast Lineages in Plasma Cells after Vaccination in Humans by Madhubanti Basu, Michael S. Piepenbrink, Czestochowa Francois, Fritzlaine Roche, Bo Zheng, David A. Spencer, Ann J. Hessell, Christopher F. Fucile, Alexander F. Rosenberg, Catherine A. Bunce, Jane Liesveld, Michael C. Keefer, James J. Kobie

    Published 2020-05-01
    Get full text
    Article
  4. 4
    Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis

    Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis by David A. Spencer, Benjamin S. Goldberg, Shilpi Pandey, Tracy Ordonez, Jérémy Dufloo, Philip Barnette, William F. Sutton, Heidi Henderson, Rebecca Agnor, Lina Gao, Timothée Bruel, Olivier Schwartz, Nancy L. Haigwood, Margaret E. Ackerman, Ann J. Hessell

    Published 2022-02-01
    Get full text
    Article
  5. 5
    Accuracy of the interpretation of chest radiographs for the diagnosis of paediatric pneumonia.

    Accuracy of the interpretation of chest radiographs for the diagnosis of paediatric pneumonia. by Mohamed A Elemraid, Michelle Muller, David A Spencer, Stephen P Rushton, Russell Gorton, Matthew F Thomas, Katherine M Eastham, Fiona Hampton, Andrew R Gennery, Julia E Clark, North East of England Paediatric Respiratory Infection Study Group

    Published 2014-01-01
    Get full text
    Article
  6. 6
    Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development

    Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development by Delphine C. Malherbe, Constantinos Kurt Wibmer, Molati Nonyane, Jason Reed, D. Noah Sather, David A. Spencer, Jason T. Schuman, Biwei Guo, Shilpi Pandey, Harlan Robins, Byung Park, Deborah H. Fuller, Jonah B. Sacha, Penny L. Moore, Penny L. Moore, Penny L. Moore, Penny L. Moore, Ann J. Hessell, Nancy L. Haigwood, Nancy L. Haigwood

    Published 2020-06-01
    Get full text
    Article
  7. 7
    Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice.

    Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice. by Catarina E Hioe, Guangming Li, Xiaomei Liu, Ourania Tsahouridis, Xiuting He, Masaya Funaki, Jéromine Klingler, Alex F Tang, Roya Feyznezhad, Daniel W Heindel, Xiao-Hong Wang, David A Spencer, Guangnan Hu, Namita Satija, Jérémie Prévost, Andrés Finzi, Ann J Hessell, Shixia Wang, Shan Lu, Benjamin K Chen, Susan Zolla-Pazner, Chitra Upadhyay, Raymond Alvarez, Lishan Su

    Published 2022-01-01
    Get full text
    Article
  8. 8
    Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge

    Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge by Delphine C. Malherbe, Lo Vang, Jason Mendy, Philip T. Barnette, David A. Spencer, Jason Reed, Bettie W. Kareko, D. Noah Sather, D. Noah Sather, Shilpi Pandey, Constantinos K. Wibmer, Constantinos K. Wibmer, Harlan Robins, Deborah H. Fuller, Byung Park, Samir K. Lakhashe, Samir K. Lakhashe, James M. Wilson, Michael K. Axthelm, Ruth M. Ruprecht, Ruth M. Ruprecht, Penny L. Moore, Penny L. Moore, Penny L. Moore, Penny L. Moore, Jonah B. Sacha, Jonah B. Sacha, Jonah B. Sacha, Ann J. Hessell, Jeff Alexander, Nancy L. Haigwood, Nancy L. Haigwood

    Published 2021-02-01
    Get full text
    Article

Search Tools: